Literature DB >> 15306103

Prognostic value of microscopic venous invasion in renal cell carcinoma: long-term follow-up.

Hervé Lang1, Véronique Lindner, Hervé Letourneux, Mael Martin, Christian Saussine, Didier Jacqmin.   

Abstract

OBJECTIVE: To assess the prognostic value of microscopic venous invasion (MVI) in a long-term follow-up series. PATIENTS AND
METHOD: 255 patients had a radical nephrectomy between 1980 and 1990 for pT1 to pT3b N0 M0 renal cell carcinoma. We reviewed the disease free, specific and overall survival after 183 months of median follow-up. Survival analyses using Kaplan-Meier and Log-rank models for univariate comparisons and Cox proportional hazards model for multivariate analyses were performed. The studied variables were: age, size, side, extracapsular invasion, renal vein invasion, local stage, Fuhrman's grade and MVI.
RESULTS: MVI was found in 74 cases (29%). The MVI was strongly correlated to metastases appearance and survival (p < 0.0001). Multivariate analysis of disease free survival showed the following independent variables: size (p < 0.0001) and Fuhrman's grade (p < 0.0001). For cancer specific survival, the analysis found size (p < 0.0001), age (p = 0.0005), Fuhrman's grade (p = 0.0035) and MVI (p = 0.016) with a relative risk of cancer related death of 2.16. Independent prognostic factors of overall survival were age (p < 0.0001), size (p < 0.0001), MVI (p = 0.015) and Fuhrman's grade (p = 0.045). The relative risk of cancer related death for MVI is 1.82.
CONCLUSION: It seems that MVI is an independent prognostic factor of survival for patients with pT1 to pT3b N0 M0 renal cell carcinoma.

Entities:  

Mesh:

Year:  2004        PMID: 15306103     DOI: 10.1016/j.eururo.2004.03.020

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  10 in total

1.  Microvascular invasion as a prognostic indicator in renal cell carcinoma: a systematic review and meta-analysis.

Authors:  Hai Huang; Xiu-Wu Pan; Yi Huang; Dan-Feng Xu; Xin-Gang Cui; Lin Li; Yi Hong; Lu Chen; Yi Gao; Lei Yin
Journal:  Int J Clin Exp Med       Date:  2015-07-15

2.  Synchronous ipsilateral renal cell carcinoma and urothelial carcinoma of the renal pelvis.

Authors:  Mike Leveridge; Phillip A Isotalo; Alexander H Boag; Jun Kawakami
Journal:  Can Urol Assoc J       Date:  2009-02       Impact factor: 1.862

3.  Association of microvascular and capillary-lymphatic invasion with outcome in patients with renal cell carcinoma.

Authors:  Manuel S Eisenberg; John C Cheville; R Houston Thompson; Dharam Kaushik; Christine M Lohse; Stephen A Boorjian; Brian A Costello; Bradley C Leibovich
Journal:  J Urol       Date:  2013-01-23       Impact factor: 7.450

4.  Urinary collecting system invasion reflects adverse long-term outcome and is associated with simultaneous metastatic spread at the time of surgery and with multilocular dissemination during postsurgical follow-up in renal cell cancer.

Authors:  Sabine Brookman-Amissah; Matthias May; Knut Albrecht; Thomas Herrmann; Jan Roigas; Christian Peter Gilfrich; Sandra Pflanz; Sven Gunia
Journal:  World J Urol       Date:  2009-05-29       Impact factor: 4.226

Review 5.  Management of inferior vena cava tumor thrombus in locally advanced renal cell carcinoma.

Authors:  Sarah P Psutka; Bradley C Leibovich
Journal:  Ther Adv Urol       Date:  2015-08

6.  A pilot study of nuclear instability in archived renal and upper urinary tract tumours with putative ochratoxin aetiology.

Authors:  Peter G Mantle; Cyrille Amerasinghe; Amy L Brown; Diana Herman; Thomas Horn; Thoger Krogh; Edward W Odell; Tomas Rosenbaum; Calin A Tatu
Journal:  Toxins (Basel)       Date:  2010-03-09       Impact factor: 4.546

7.  Prognosis of metastatic renal cell carcinoma with first-line interferon-α therapy in the era of molecular-targeted therapy.

Authors:  Yoshiaki Kawano; Wataru Takahashi; Masatoshi Eto; Tomomi Kamba; Hideaki Miyake; Masato Fujisawa; Takao Kamai; Hirotsugu Uemura; Taiji Tsukamoto; Haruhito Azuma; Akio Matsubara; Kazuo Nishimura; Tsuyoshi Nakamura; Osamu Ogawa; Seiji Naito
Journal:  Cancer Sci       Date:  2016-06-14       Impact factor: 6.716

8.  Verification of the International Society of Urological Pathology recommendations in Japanese patients with clear cell renal cell carcinoma.

Authors:  Hakushi Kim; Chie Inomoto; Takato Uchida; Hiroyuki Furuya; Tomoyoshi Komiyama; Hiroshi Kajiwara; Hiroyuki Kobayashi; Naoya Nakamura; Akira Miyajima
Journal:  Int J Oncol       Date:  2018-02-28       Impact factor: 5.650

Review 9.  Prognostic Factors for Localized Clear Cell Renal Cell Carcinoma and Their Application in Adjuvant Therapy.

Authors:  Kalle E Mattila; Paula Vainio; Panu M Jaakkola
Journal:  Cancers (Basel)       Date:  2022-01-04       Impact factor: 6.639

10.  Evaluation of microvascular invasion as a prognostic factor in the progression of non-metastatic renal cancer.

Authors:  Rubén G Bengió; Leandro Cristian Arribillaga; Javier Epelde; Sergio Orellana; Ariel Montedoro; Verónica Bengió; Esteban Cordero; Matías Guevara
Journal:  Cent European J Urol       Date:  2018-10-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.